Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Potassium Channel
    (2)
  • AAK1
    (1)
  • AAK1 (AP2 associated kinase 1)
    (1)
  • GluR
    (1)
  • LPL Receptor
    (1)
  • P2X Receptor
    (1)
  • P2Y Receptor
    (1)
  • Sodium Channel
    (1)
  • Others
    (6)
TargetMol | Tags By ResearchField
  • Nervous System
    (3)
  • Cancer
    (1)
Filter
Search Result
Results for "

sciatic

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    12
    TargetMol | All_Pathways
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
Sivopixant
Sivopixant, S-600918
T400452414285-40-6
Sivopixant (S-600918) (S-600918) is a potent and selective antagonist of P2X3 receptor (P2X3 IC 50 =4.2 nM; P2X2/3 IC 50 =1100 nM). Sivopixant shows strong analgesic effect .
  • $89
In Stock
Size
QTY
TargetMol | Citations Cited
HW161023
T2068962920698-73-1
HW161023 (compound) is an orally active inhibitor of AP2 associated protein kinase 1 (AAK1), exhibiting IC50 values of 5.4 nM for AAK1 and 11.9 μM for hERG. HW161023 can suppress pain response in a rat model of chronic sciatic nerve compression injury.
  • Inquiry Price
10-14 weeks
Size
QTY
Z-4105
T213140119737-52-9
Z-4105 (formula l) is a nootropic compound. It reverses the amnesia effects induced by electroconvulsive shock (ECS) and methylazoxymethanol acetate (MAM), thereby improving learning and memory functions. The compound enhances the activity of the brain's cholinergic system without affecting other neurotransmitter systems. Additionally, Z-4105 significantly alleviates neuropathic pain caused by chronic constriction injury (CCl) in rat sciatic nerve and spinal nerve ligament models. It is utilized in research on neuropathic pain and cognitive dysfunction.
  • Inquiry Price
10-14 weeks
Size
QTY
MRS4917
T213345
MRS4917 is a potent and selective orally active P2Y14 receptor (hP2Y14R) antagonist, with an IC50 of 2.88 nM and a Ki of 1.67 nM, demonstrating over 18,000-fold selectivity against P2Y6R (IC50= 54 μM). It effectively reverses established mechanical allodynia in a chronic sciatic nerve compression (CCI) mouse model without affecting thermoregulation when administered orally. MRS4917 is applicable for research in neurological disorders.
  • Inquiry Price
Inquiry
Size
QTY
E0199
T213374931928-13-1
E0199 is an innovative and potent KV7/NaV dual-target modulator that activates KV7 potassium channels, including KV7.2/7.3 (EC50 = 12.78 nM), KV7.2 (EC50 = 0.50 μM), and KV7.5 (EC50 = 27.14 nM), while inhibiting NaV1.7 (IC50 = 0.52 μM), NaV1.8 (IC50 = 0.24 μM), and NaV1.9 (IC50 = 0.16 μM) sodium channels. In a mouse model of chronic constriction injury (CCI) to the sciatic nerve, E0199 demonstrated potent analgesic effects without significant impact on cardiac and skeletal muscle ion channels. E0199 is applicable in studies related to neuropathic pain (NP).
  • Inquiry Price
10-14 weeks
Size
QTY
QO-58
QO58
T284831259536-62-3
QO-58 is a novel Kv7 activator (opener) that activates neuronal Kv7/KCNQ/M channels, dose-dependently activating Kv7 currents, enhancing native neuronal M currents, and causing a decrease in evoked action potentials. It has anti-nociceptive effects on inflammatory pain and can be used for neuronal excitability disorders.
  • $299
In Stock
Size
QTY
AUY-954 free base
NVP-AUY954, AUY-954, AUY954, AUY 954
T30215820240-77-5
AUY-954 is an effective selective S1P(1) modulator. It can significantly reduce the local expression of EAN rat sciatic nerve T cells, B cells, macrophage infiltration, inflammatory demyelination, interleukin-17 and matrix metalloproteinase-9.
  • $246
35 days
Size
QTY
C22 dihydro 1-Deoxyceramide (m18:0/22:0)
C22 dihydro 1-Deoxyceramide (m18:0/22:0)
T38280
C22 dihydro 1-Deoxyceramide (m18:0/22:0) is a very long-chain atypical ceramide containing a 1-deoxysphinganine backbone. 1-Deoxysphingolipids are formed when serine palmitoyltransferase condenses palmitoyl-CoA with alanine instead of serine during sphingolipid synthesis.1,2 C22 dihydro 1-Deoxyceramide (m18:0/22:0) has been found in mouse embryonic fibroblasts (MEFs) following application of 1-deoxysphinganine alkyne or 1-deoxysphinganine-d3.3 It has also been found as the most prevalent dihydro deoxyceramide species in mouse brain, spinal cord, and sciatic nerve at one, three, and six months of age.4 |1. Steiner, R., Saied, E.M., Othman, A., et al. Elucidating the chemical structure of native 1-deoxysphingosine. J. Lipid Res. 57(7), 1194-1203 (2016).|2. Alecu, I., Othman, A., Penno, A., et al. Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway. J. Lipid Res. 58(1), 60-71 (2017).|3. Alecu, I., Tedeschi, A., Behler, N., et al. Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction. J. Lipid. Res. 58(1), 42-59 (2017).|4. Schwartz, N.U., Mileva, I., Gurevich, M., et al. Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue. Prostaglandins Other Lipid Mediat. 141, 40-48 (2019).
  • $243
35 days
Size
QTY
C24 dihydro 1-Deoxyceramide (m18:0/24:0)
C24 dihydro 1-Deoxyceramide (m18:0/24:0)
T382841645269-63-1
C24 dihydro 1-Deoxyceramide (m18:0/24:0) is a very long-chain atypical ceramide containing a 1-deoxysphinganine backbone. 1-Deoxysphingolipids are formed when serine palmitoyltransferase condenses palmitoyl-CoA with alanine instead of serine during sphingolipid synthesis.1,2 C24 dihydro 1-Deoxyceramide (m18:0/24:0) has been found in mouse embryonic fibroblasts (MEFs) following application of 1-deoxysphinganine alkyne or 1-deoxysphinganine-d3.3 It has also been found in mouse brain, spinal cord, and sciatic nerve at one, three, and six months of age.4 |1. Steiner, R., Saied, E.M., Othman, A., et al. Elucidating the chemical structure of native 1-deoxysphingosine. J. Lipid Res. 57(7), 1194-1203 (2016).|2. Alecu, I., Othman, A., Penno, A., et al. Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway. J. Lipid Res. 58(1), 60-71 (2017).|3. Alecu, I., Tedeschi, A., Behler, N., et al. Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction. J. Lipid. Res. 58(1), 42-59 (2017).|4. Schwartz, N.U., Mileva, I., Gurevich, M., et al. Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue. Prostaglandins Other Lipid Mediat. 141, 40-48 (2019).
  • $292
Inquiry
Size
QTY
(S)-4CPG
(S)-4-Carboxyphenylglycine
T5507134052-73-6
(S)-4CPG ((S)-4-Carboxyphenylglycine) is a competitive mGlu1 receptor antagonist that attenuates nociceptive hypersensitivity and nociceptive abnormalities associated with sciatic nerve constriction injuries in rats, and may be used in the study of neurological disorders.
  • $31
In Stock
Size
QTY
Melanotan II acetate
T715591036322-26-5
Melanotan II acetate is an agonist of melanocortin receptor 1 (MC1R), MC3R, MC4R, and MC5R. It has been shown to improve recovery of sciatic nerve function after mechanical injury and increase cisplatin-induced decreases in sensory nerve conduction velocity. Melanotan II acetate increases oxygen consumption and protein levels of uncoupling protein 1 (UCP1) in brown adipose tissue homogenates and decreases food intake, body weight, and serum levels of leptin, glucose, insulin, and cholesterol.
  • $1,520
6-8 weeks
Size
QTY
1,2-Dilaurin
1,2-Dilaurin, (Rac)-1,2-Didodecanoylglycerol
TCL-0002617598-94-6
1,2-Dilaurin is a diacylglycerol compound with lauric acid at the sn-1 and sn-2 positions. It is utilized as an internal standard for quantifying diacylglycerols in desheathed rat sciatic nerves. Monomolecular films containing 1,2-dilauroyl-rac-glycerol serve as substrates to assess surface pressure and the effects of procolipase and colipase on porcine pancreatic lipase activity.
  • $157
35 days
Size
QTY